PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31970483-2	2020	However, 25(OH)D is predominantly bound to vitamin D-binding protein (VDBP), and it has been reported that the free-25(OH)D and 25(OH)D loosely bound to albumin fraction correlates better with clinical outcomes.	25-hydroxyvitamin D3-bromoacetate	9-16	GC vitamin D binding protein	Homo sapiens	43-68	
31970483-2	2020	However, 25(OH)D is predominantly bound to vitamin D-binding protein (VDBP), and it has been reported that the free-25(OH)D and 25(OH)D loosely bound to albumin fraction correlates better with clinical outcomes.	25-hydroxyvitamin D3-bromoacetate	9-16	GC vitamin D binding protein	Homo sapiens	70-74	
31970483-8	2020	In the transplant group, measured free-25(OH)D concentrations were predicted by both total-25(OH)D and VDBP concentrations (beta = 0.6, - 0.6, respectively; R2 = 80%).	25-hydroxyvitamin D3-bromoacetate	39-46	GC vitamin D binding protein	Homo sapiens	103-107	
31837045-4	2020	Pearson"s correlation analysis was applied to evaluate the association between serum VDBP and 25(OH)D levels in CRC.	25-hydroxyvitamin D3-bromoacetate	94-101	GC vitamin D binding protein	Homo sapiens	85-89	
31676954-3	2020	Free 25(OH)D can be calculated mathematically by Bikle method from the concentrations of total 25(OH)D, VDBP, and albumin or measured directly by ELISA.	25-hydroxyvitamin D3-bromoacetate	5-12	GC vitamin D binding protein	Homo sapiens	104-108	
31676954-2	2020	The majority of serum 25(OH)D is bound to vitamin D-binding protein (VDBP) (~ 85%) and to albumin (~ 15%), with only a miniscule amount circulating as free 25(OH)D.	25-hydroxyvitamin D3-bromoacetate	22-29	GC vitamin D binding protein	Homo sapiens	42-67	
31676954-2	2020	The majority of serum 25(OH)D is bound to vitamin D-binding protein (VDBP) (~ 85%) and to albumin (~ 15%), with only a miniscule amount circulating as free 25(OH)D.	25-hydroxyvitamin D3-bromoacetate	22-29	GC vitamin D binding protein	Homo sapiens	69-73	
31708871-9	2019	However, since 25(OH)D is transported in serum bound primarily to vitamin D binding protein (DBP) and secondarily to albumin, is the total 25(OH)D (bound plus free) or the unbound free 25(OH)D the crucial determinant of the non-classical actions of vitamin D?	25-hydroxyvitamin D3-bromoacetate	15-22	GC vitamin D binding protein	Homo sapiens	66-91	
32033150-2	2020	Cancer cells are believed to take up bioavailable 25-hydroxyvitamin D (25[OH]D) (i.e., not bound to vitamin-D-binding protein (DBP)) more efficiently than DBP-bound 25(OH)D.	25-hydroxyvitamin D3-bromoacetate	165-172	GC vitamin D binding protein	Homo sapiens	155-158	
32033150-4	2020	The bioavailable 25(OH)D levels were calculated via an equation using data of serum total 25(OH)D, albumin, and DBP levels, and DBP genotypes (rs7041 and rs4588).	25-hydroxyvitamin D3-bromoacetate	17-24	GC vitamin D binding protein	Homo sapiens	112-115	
32033150-4	2020	The bioavailable 25(OH)D levels were calculated via an equation using data of serum total 25(OH)D, albumin, and DBP levels, and DBP genotypes (rs7041 and rs4588).	25-hydroxyvitamin D3-bromoacetate	17-24	GC vitamin D binding protein	Homo sapiens	128-131	
31571953-3	2019	Vitamin-D binding protein (VDBP) acts as a major 25(OH)D transporter.	25-hydroxyvitamin D3-bromoacetate	49-56	GC vitamin D binding protein	Homo sapiens	0-25	
31571953-3	2019	Vitamin-D binding protein (VDBP) acts as a major 25(OH)D transporter.	25-hydroxyvitamin D3-bromoacetate	49-56	GC vitamin D binding protein	Homo sapiens	27-31	
31555688-3	2019	Herein we aimed to present novel evidence on the association of two VDBP polymorphisms (rs4588) and (rs7041) with CAD in patients after acute myocardial infarction and study possible correlations of these polymorphisms with 25-hydroxyvitamin D [25(OH)D] serum levels.	25-hydroxyvitamin D3-bromoacetate	245-252	GC vitamin D binding protein	Homo sapiens	68-72